tecartushcp.com - CAR T for R/R MCL and R/R B-­cell ALL | TECARTUS® HCP Website

home > domains > tecartushcp.com

Description: Learn about TECARTUS®—a CAR T-cell therapy for adults with R/R mantle cell lymphoma and R/R acute lymphoblastic leukemia. See full PI, including BOXED WARNING.

Example domain paragraphs

TECARTUS ® (brexucabtagene autoleucel) is a CD19-directed genetically modified autologous T cell immunotherapy indicated Read more +

TECARTUS® (brexucabtagene autoleucel) is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL). This indication is approved under accelerated approval based on overall response rate and durability Read more +

TECARTUS ® (brexucabtagene autoleucel) is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL). This indication is approved under accelerated approval based on overall response rate and durability of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial. TECARTUS is a CD19-directed genetically modified

Links to tecartushcp.com (2)

• tecartus.com TECARTUS® (brexucabtagene autoleucel) Patient & Caregiver Site | CAR T-Cell Therapy for Mantle Cell Lymphoma
• powerofkite.com